Zymeworks Inc.
Total Trades
51
Buys
19
Sells
16
Largest Trade
N/A
Insiders
8
Institutional Funds
155
Inst. Value
$1M+
Activist Filings
50
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Hollywood Mark | COO | EXERCISE | N/A | 18K | — | Jan 13, 2026 |
| Hollywood Mark | COO | SELL | $100K–$500K | 6K | $22.67 | Jan 13, 2026 |
| Smith Jeffrey T L | EVP & Chief Medica… | EXERCISE | N/A | 18K | — | Jan 13, 2026 |
| Smith Jeffrey T L | EVP & Chief Medica… | SELL | $100K–$500K | 9K | $22.67 | Jan 13, 2026 |
| Moore Paul Andrew | Chief Scientific O… | EXERCISE | N/A | 18K | — | Jan 13, 2026 |
| Moore Paul Andrew | Chief Scientific O… | SELL | $100K–$500K | 10K | $22.67 | Jan 13, 2026 |
| Galbraith Kenneth | Chair & CEO | SELL | $500K+ | 30K | $22.67 | Jan 13, 2026 |
| Galbraith Kenneth | Chair & CEO | EXERCISE | N/A | 64K | — | Jan 13, 2026 |
| Smith Jeffrey T L | EVP & Chief Medica… | SELL | $100K–$500K | 11K | $25.10 | Jan 6, 2026 |
| Smith Jeffrey T L | EVP & Chief Medica… | EXERCISE | N/A | 20K | — | Jan 6, 2026 |
| Galbraith Kenneth | Chair & CEO | SELL | $1M+ | 54K | $25.10 | Jan 6, 2026 |
| Galbraith Kenneth | Chair & CEO | EXERCISE | N/A | 114K | — | Jan 6, 2026 |
| Moore Paul Andrew | Chief Scientific O… | SELL | $500K+ | 20K | $25.10 | Jan 6, 2026 |
| Moore Paul Andrew | Chief Scientific O… | EXERCISE | N/A | 37K | — | Jan 6, 2026 |
| Galbraith Kenneth | Chair & CEO | EXERCISE | N/A | 100K | — | Dec 22, 2025 |
| Galbraith Kenneth | Chair & CEO | SELL | $1M+ | 48K | $27.02 | Dec 22, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $500K+ | 55K | $11.47 | May 19, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 129K | $11.32 | Apr 18, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 317K | $11.42 | Apr 7, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 127K | $11.75 | Apr 2, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 97K | $12.61 | Mar 27, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 127K | $12.92 | Mar 24, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 228K | $12.55 | Mar 19, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 1.1M | $12.13 | Mar 13, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 141K | $13.88 | Jan 21, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 168K | $13.59 | Jan 15, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 225K | $13.21 | Jan 10, 2025 |
| Moore Paul Andrew | Chief Scientific O… | EXERCISE | N/A | 37K | — | Jan 7, 2025 |
| Moore Paul Andrew | Chief Scientific O… | SELL | $100K–$500K | 21K | $14.92 | Jan 7, 2025 |
| Galbraith Kenneth | Chair & CEO | SELL | $500K+ | 57K | $14.92 | Jan 7, 2025 |
| Galbraith Kenneth | Chair & CEO | EXERCISE | N/A | 114K | — | Jan 7, 2025 |
| Smith Jeffrey T L | EVP & Chief Medica… | EXERCISE | N/A | 20K | — | Jan 7, 2025 |
| Smith Jeffrey T L | EVP & Chief Medica… | SELL | $100K–$500K | 11K | $14.92 | Jan 7, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 363K | $14.64 | Jan 2, 2025 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 130K | $14.44 | Dec 27, 2024 |
| EcoR1 Capital, LLC | 10% Owner | BUY | $1M+ | 3.4M | $8.12 | Jun 21, 2023 |
| EcoR1 Capital, LLC | 10% Owner | BUY | $1M+ | 200K | $8.00 | Mar 30, 2023 |
| Klompas Neil A | President & COO | EXERCISE | N/A | 5K | — | Mar 14, 2023 |
| Klompas Neil A | President & COO | SELL | $15K–$50K | 3K | $7.83 | Mar 14, 2023 |
| EcoR1 Capital, LLC | 10% Owner | BUY | $1M+ | 308K | $9.70 | Jan 23, 2023 |
| EcoR1 Capital, LLC | 10% Owner | BUY | $1M+ | 985K | $9.84 | Jan 18, 2023 |
| EcoR1 Capital, LLC | 10% Owner | BUY | $1M+ | 1.0M | $7.67 | Jan 12, 2023 |
| Astle Christopher | CFO | EXERCISE | N/A | 2K | — | Dec 15, 2022 |
| Astle Christopher | CFO | SELL | $1K–$15K | 887 | $6.01 | Dec 15, 2022 |
| Josephson Neil | Chief Medical Offi… | SELL | $15K–$50K | 2K | $8.10 | Nov 15, 2022 |
| Josephson Neil | Chief Medical Offi… | EXERCISE | N/A | 6K | — | Nov 15, 2022 |
| Josephson Neil | Chief Medical Offi… | EXERCISE | N/A | 6K | — | Nov 15, 2022 |
| Josephson Neil | Chief Medical Offi… | SELL | $15K–$50K | 2K | $8.10 | Nov 15, 2022 |
| Klompas Neil A | COO | SELL | $15K–$50K | 3K | $6.88 | Mar 12, 2022 |
| Klompas Neil A | COO | EXERCISE | N/A | 5K | — | Mar 12, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 155 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Rubric Capital Management LP | 5.8M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 3.3M | $1M+ | SH |
| Siren, L.L.C. | 1.7M | $1M+ | SH |
| Nextech Invest, Ltd. | 1.1M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 1.1M | $1M+ | SH |
| STATE STREET CORP | 1.0M | $1M+ | SH |
| Capricorn Fund Managers Ltd | 1.0M | $1M+ | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 700K | $1M+ | SH |
| Assenagon Asset Management S.A. | 647K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 593K | $1M+ | SH |
| Prosight Management, LP | 530K | $1M+ | SH |
| Redmile Group, LLC | 492K | $1M+ | SH |
| Schonfeld Strategic Advisors LLC | 289K | $1M+ | SH |
| PICTON MAHONEY ASSET MANAGEMENT | 245K | $1M+ | SH |
| Hillsdale Investment Management Inc. | 238K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 221K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 221K | $1M+ | SH |
| KENNEDY CAPITAL MANAGEMENT LLC | 146K | $1M+ | SH |
| JUPITER ASSET MANAGEMENT LTD | 126K | $1M+ | SH |
| HRT FINANCIAL LP | 121K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 13, 2026
7.7%
5.8M shares
SC 13G/A · Feb 12, 2026
3.4%
2.5M shares
SC 13D/A · Nov 19, 2025
30.7%
23.0M shares
SC 13G/A · Nov 14, 2025
2.7%
2.0M shares
SC 13G/A · Nov 14, 2025
4.9%
3.7M shares
SC 13G/A · Aug 14, 2025
5.6%
4.2M shares
SC 13G/A · Jul 16, 2025
4.8%
3.6M shares
SC 13D · Jun 27, 2025
30.7%
23.0M shares
SC 13G/A · May 7, 2025
5.8%
4.1M shares
SC 13D/A · Apr 8, 2025
25.4%
17.7M shares
SC 13D/A · Mar 17, 2025
24.2%
16.9M shares
SC 13D/A · Feb 18, 2025
22.8%
15.7M shares
SC 13G/A · Feb 15, 2025
7.0%
4.8M shares
SC 13D/A · Jan 14, 2025
22.4%
15.4M shares
SC 13D/A · Dec 24, 2024
21.3%
14.7M shares
SC 13G/A · Nov 15, 2024
7.2%
5.1M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Nov 14, 2024
3.4%
2.4M shares
SC 13G · Nov 13, 2024
5.5%
3.9M shares
SC 13D · Feb 23, 2024
20.0%
14.1M shares
SC 13G/A · Feb 14, 2024
20.0%
14.1M shares
SC 13G/A · Feb 14, 2024
1.5%
1.1M shares
SC 13G/A · Feb 14, 2024
8.3%
5.8M shares
SC 13G/A · Feb 14, 2024
0.0%
27K shares
SC 13G · Jan 29, 2024
5.6%
3.9M shares
SC 13G/A · Jun 21, 2023
19.9%
13.4M shares
SC 13G/A · Feb 14, 2023
9.8%
6.2M shares
SC 13G/A · Feb 14, 2023
5.9%
3.8M shares
Eventide Asset Management, LLC
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 14, 2023
7.2%
4.5M shares
BANK OF AMERICA CORPORATION 56-0906609
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 10, 2023
4.6%
2.9M shares
Morgan Stanley I.R.S. # 36-3145972
SC 13G · Feb 10, 2023
8.9%
5.6M shares
SC 13G/A · Feb 2, 2023
3.9%
2.4M shares
Biotechnology Value Fund, L.P.
SC 13G · Jan 3, 2023
5.0%
3.1M shares
SC 13D/A · Dec 28, 2022
4.4%
2.8M shares
SC 13D/A · Dec 28, 2022
4.4%
2.8M shares
SC 13G/A · Nov 1, 2022
12.0%
7.6M shares
SC 13G · Oct 28, 2022
9.9%
6.0M shares
SC 13G · Oct 17, 2022
10.1%
6.1M shares
SC 13G · Aug 8, 2022
9.9%
5.8M shares
SC 13D/A · May 26, 2022
6.9%
4.0M shares
SC 13D/A · May 20, 2022
5.9%
3.4M shares
SC 13D/A · Apr 28, 2022
5.9%
3.4M shares
SC 13D · Apr 22, 2022
5.9%
3.4M shares
SC 13G/A · Mar 10, 2022
1.2%
687K shares
SC 13G/A · Feb 15, 2022
6.6%
3.7M shares
SC 13G/A · Feb 14, 2022
10.0%
5.0M shares
SC 13G · Feb 14, 2022
5.3%
2.5M shares
Eventide Asset Management, LLC
SC 13G · Feb 14, 2022
6.1%
2.8M shares
Morgan Stanley I.R.S. # 36-3145972
SC 13G/A · Feb 11, 2022
4.5%
2.1M shares